Chiasma Files Mycapssa European Application For Acromegaly

Chiasma's Mycapssa Associated With Positive Patient-Reported Outcomes In Acromegaly Patients

Why Chiasma's Stock Is Surging Today

Hot Penny Stocks to Buy? 3 to Watch on Cinco De Mayo

CHMA Stock: From $2.84 To $4.07 (43.31% Increase) Pre-Market Explanation

CHMA Stock Price Increases Over 10% Pre-Market: Why It Happened

Orphan Drugs Market Overview 2020, Industry Size, Drugs Development Pipeline, Key Players, Market Comparison Analysis and Share Analysis, Forecast to 2023

The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings

-$0.40 EPS Expected for Chiasma Inc (NASDAQ:CHMA) This Quarter

The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes

The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts

The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions

Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates